CN108904710A - It is a kind of for treating the externally applied ointment and manufacturing method of bruise and rheumatism bone disease - Google Patents
It is a kind of for treating the externally applied ointment and manufacturing method of bruise and rheumatism bone disease Download PDFInfo
- Publication number
- CN108904710A CN108904710A CN201810722467.5A CN201810722467A CN108904710A CN 108904710 A CN108904710 A CN 108904710A CN 201810722467 A CN201810722467 A CN 201810722467A CN 108904710 A CN108904710 A CN 108904710A
- Authority
- CN
- China
- Prior art keywords
- parts
- externally applied
- radix
- applied ointment
- bruise
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
Abstract
The present invention relates to a kind of for treating fracture bruise with the externally applied ointment and manufacturing method of rheumatism bone disease.Externally applied ointment provided by the invention is using simple, easy to operate, cure rate is high, has no toxic side effect.The effective percentage of fracture, acute and chronic bruise, lumbar muscle strain, prolapse of lumbar intervertebral disc, gonarthromeningitis, facial paralysis is treated 98% or more；The effective percentage of cervical spondylosis, scapulohumeral periarthritis, tennis elbow, talagia, rheumatoid arthritis, caput femoris necrosis, ankylosing spondylitis is treated 92% or more.
Description
Technical field
The present invention relates to a kind of externally applied ointments, and in particular to one kind is for treating fracture acute and chronic bruise and rheumatic bone
The externally applied ointment and its manufacturing method of disease.
Background technique
With the improvement of living standards with people's life-time dilatation, unfavorable to the body life and work habit minister of public works in ancient china is shown in
It is used, such as the race of bowing of mobile phone, the person of bending over one's desk working, white collar are played, these crowds often will appear overweight, thermophilic cigarette is addicted to drink, and cause
Make occur Low Back Pain, sciatica, lower limb numbness distending pain in crowd, has a stiff neck, dizzy, hand fiber crops, nausea and vomiting, Shou Zuwu
Power does not walk that the phenomenon that symptoms such as a long way is more and more, and the trend that oriented young crowd stretches, this is all cervical spondylosis, lumbar vertebrae
The illness that disk protrusion, spinal canal stenosis, hyperosteogeny slip is done mischief.
Since interverbebral disc is vesselless tissue, oral drugs and general ointment composition are unable to reach lesion, cause to control long
It is not cured, majority can only alleviate slight illness, but once stop treatment, and recur using traction, massage, acupuncture, massage manipulation treatment
, it is serious in addition need have an operation, increase the physical pain of patient, aggravated financial burden and mental burden, shadow
The work, life and happy family life of patient are rung.
In addition, present social pressures are bigger, in rural area, major part labour, which goes out to do manual work, is engaged in outwork, always
Child people, which is in, also often rides electric vehicle tricycle, and due to working, accidentally tumble injury soft tissue injury and fracture is several
Rate is very high, brings unexpected pain to patient.
Summary of the invention
The main object of the present invention is to provide a kind of for treating the external application of fracture acute and chronic bruise and rheumatism bone disease
Plaster.
In order to complete above-mentioned purpose, the present invention provides one kind for treating fracture acute and chronic bruise and rheumatism bone disease
Externally applied ointment, the composition component of the plaster is by weight ratio:20 ~ 30 parts of lopseed, 15 ~ 20 parts of Big White Flower snake, gecko
5 ~ 10 parts, 20 ~ 30 parts of Eupolyphoge sinensis, 25 ~ 35 parts of Resina Draconis, 20 ~ 25 parts of the rhizome of davallia, 35 ~ 40 parts of safflower, 15 ~ 20 parts of Rhizoma Gastrodiae, Cortex Eucommiae 15
~ 20 parts, 30 ~ 40 parts of Caulis Spatholobi, 55 ~ 65 parts of pangolin, 20 ~ 30 parts of leech, 15 ~ 20 parts of hippocampus, 30 ~ 35 parts of olibanum, myrrh 30 ~
35 parts, 10 ~ 15 parts of Rhizoma Arisaematis (processed), 20 ~ 25 parts of native copper, 20 ~ 30 parts of corydalis tuber, 5 ~ 10 parts of the bletilla striata, 10 ~ 15 parts of aconiti preparata,radix, wild aconite root
10 ~ 15 parts, 20 ~ 30 parts of Radix Angelicae Sinensis, 20 ~ 30 parts of Radix Astragali, 20 ~ 30 parts of radix dipsaci, 550 parts of yellow lead.
In addition, the present invention also provides a kind of for treating the externally applied ointment of fracture acute and chronic bruise and rheumatism bone disease
Manufacturing method comprising step below：
S1：Obtain following material：20 ~ 30 parts of lopseed, 15 ~ 20 parts of Big White Flower snake, 5 ~ 10 parts of gecko, 20 ~ 30 parts of Eupolyphoge sinensis, dragon's blood
Exhaust 25 ~ 35 parts, 20 ~ 25 parts of the rhizome of davallia, 35 ~ 40 parts of safflower, 15 ~ 20 parts of Rhizoma Gastrodiae, 15 ~ 20 parts of Cortex Eucommiae, 30 ~ 40 parts of Caulis Spatholobi, water
20 ~ 30 parts of leech, 30 ~ 35 parts of olibanum, 30 ~ 35 parts of myrrh, 10 ~ 15 parts of Rhizoma Arisaematis (processed), 20 ~ 30 parts of corydalis tuber, 10 ~ 15 parts of aconiti preparata,radix, system
These medicinal materials, are broken into powder by 10 ~ 15 parts of radix aconiti agrestis, 20 ~ 30 parts of Radix Angelicae Sinensis, 20 ~ 30 parts of Radix Astragali, 20 ~ 30 parts of radix dipsaci；
S2：Material after S1 is smashed is impregnated 10 days to 20 days with 1.2 kilograms of sesame oil；
S3：The dregs of a decoction, which are filtered out, with 100 mesh sieve after tanning is further continued for oil of decocting medicinal herbs；
S4：Tanning medicine oil lower 550 parts of yellow lead after dropping into a bead, is persistently stirred, the process of lower yellow lead continues 5 during lower yellow lead
To 10 minutes；
S5：It is poured slowly into cold water, impregnates 7 to 15 days after cooling, and water of replacement daily, obtain lotion；
S6:20 ~ 25 parts of native copper, 55 ~ 65 parts of pangolin, 15 ~ 20 parts of hippocampus, 5 ~ 10 parts of the bletilla striata are beaten into powder and cross the addition of 120 meshes
It into lotion, is spread out on pure cotton cloth, freezing obtained finished product externally applied ointment after 48 hours.
In addition, externally applied ointment provided by the invention, as treatment fracture, osteoproliferation, acute and chronic bruise, psoas muscle labor
Damage, prolapse of lumbar intervertebral disc, paint arthrosynovitis, facial paralysis, cervical spondylosis, scapulohumeral periarthritis, tennis elbow, talagia, rheumatoid arthritis, stock
Head necrosis, ankylosing spondylitis drug purposes.
Beneficial effects of the present invention are：The present invention is using simple, easy to operate, cure rate is high, has no toxic side effect.Treat bone
Folding, acute and chronic bruise, lumbar muscle strain, prolapse of lumbar intervertebral disc, paint arthrosynovitis, facial paralysis effective percentage 98% or more；Treat neck
Vertebra disease, scapulohumeral periarthritis, tennis elbow, talagia, rheumatoid arthritis, caput femoris necrosis, ankylosing spondylitis effective percentage 92%
More than.
Specific embodiment
In the following description, numerous specific details are set forth in order to facilitate a full understanding of the present invention, but the present invention can be with
Implemented using other than the one described here other way, those skilled in the art can be without prejudice to intension of the present invention
In the case of do similar popularization, therefore the present invention is not limited by the specific embodiments disclosed below.
First embodiment：
It present embodiments provides a kind of for treating the externally applied ointment of fracture acute and chronic bruise and rheumatism bone disease, the group of plaster
It is divided into and point is by weight ratio:20 ~ 30 parts of lopseed, 15 ~ 20 parts of Big White Flower snake, 5 ~ 10 parts of gecko, 20 ~ 30 parts of Eupolyphoge sinensis, dragon's blood
It exhausts 25 ~ 35 parts, 20 ~ 25 parts of the rhizome of davallia, 35 ~ 40 parts of safflower, 15 ~ 20 parts of Rhizoma Gastrodiae, 15 ~ 20 parts of Cortex Eucommiae, 30 ~ 40 parts of Caulis Spatholobi, wear
55 ~ 65 parts of naze, 20 ~ 30 parts of leech, 15 ~ 20 parts of hippocampus, 30 ~ 35 parts of olibanum, 30 ~ 35 parts of myrrh, 10 ~ 15 parts of Rhizoma Arisaematis (processed), from
Right 20 ~ 25 parts of copper, 20 ~ 30 parts of corydalis tuber, 5 ~ 10 parts of the bletilla striata, 10 ~ 15 parts of aconiti preparata,radix, 10 ~ 15 parts of wild aconite root, 20 ~ 30 parts of Radix Angelicae Sinensis, Huang
20 ~ 30 parts of stilbene, 20 ~ 30 parts of radix dipsaci, 550 parts of yellow lead.
In addition, the manufacturer of the externally applied ointment for treating fracture acute and chronic bruise and rheumatism bone disease of the present embodiment
Method comprising step below：
S1：Obtain following material：20 ~ 30 parts of lopseed, 15 ~ 20 parts of Big White Flower snake, 5 ~ 10 parts of gecko, 20 ~ 30 parts of Eupolyphoge sinensis, dragon's blood
Exhaust 25 ~ 35 parts, 20 ~ 25 parts of the rhizome of davallia, 35 ~ 40 parts of safflower, 15 ~ 20 parts of Rhizoma Gastrodiae, 15 ~ 20 parts of Cortex Eucommiae, 30 ~ 40 parts of Caulis Spatholobi, water
20 ~ 30 parts of leech, 15 ~ 20 parts of hippocampus, 30 ~ 35 parts of olibanum, 30 ~ 35 parts of myrrh, 10 ~ 15 parts of Rhizoma Arisaematis (processed), 20 ~ 30 parts of corydalis tuber, river processed
Black 10 ~ 15 parts, 10 ~ 15 parts of wild aconite root, 20 ~ 30 parts of Radix Angelicae Sinensis, 20 ~ 30 parts of Radix Astragali, 20 ~ 30 parts of radix dipsaci, are broken into these medicinal materials
Powder；
S2：Material after S1 is smashed is impregnated 10 days to 20 days with 1.2 kilograms of sesame oil；
S3：The dregs of a decoction, which are filtered out, with 100 mesh sieve after tanning is further continued for oil of decocting medicinal herbs；
S4：Boil medicine oil（Preferable temperature is 320 °）Lower 550 parts of yellow lead, is persistently stirred during lower yellow lead after dropping into a bead,
The process of lower yellow lead continues 5 to 10 minutes；
S5：It is poured slowly into cold water after cooling（It being capable of releasing fire-toxin）, impregnate 7 to 15 days, and water of replacement daily, obtain cream
Body；
S6:20 ~ 25 parts of native copper, 55 ~ 65 parts of pangolin, 15 ~ 20 parts of hippocampus, 5 ~ 10 parts of the bletilla striata are beaten into powder and cross the addition of 120 meshes
It into lotion, is spread out on pure cotton cloth, freezes 48 hours（Refrigerator can be used）After obtain finished product externally applied ointment.
In addition, externally applied ointment provided in this embodiment, as treatment fracture, osteoproliferation, acute and chronic bruise, psoas muscle
Strain, prolapse of lumbar intervertebral disc, paint arthrosynovitis, facial paralysis, cervical spondylosis, scapulohumeral periarthritis, tennis elbow, talagia, rheumatoid arthritis,
The purposes of the drug of caput femoris necrosis, ankylosing spondylitis.
In externally applied ointment provided in this embodiment, the effect of lopseed is treatment traumatic injury, gecko effect be wind-dispelling,
Active, dissipating bind, rheumatic arthritis, agkistrodon effect are wind-damp dispelling, and saturating muscles and bones, Eupolyphoge sinensis effect is dissipating blood stasis with potent drugs, reunion of fractured tendons and bones, dragon
Dragon's blood effect is with activating microcirculation and removing stasis medicinal, swelling and pain relieving, astringing to arrest bleeding, resolving hard lump；Rhizome of davallia effect is treatment injury and bone fracture, the stasis of blood
Swollen pain；Safflower effect is blood circulation, stasis eliminatings analgesic；Rhizoma Gastrodiae effect is Inflammation Zhijing, calming the liver, dispelling wind and removing obstruction in the meridians；Wear mountain
First effect is degrading the channel, subduing inflammation, and hippocampus effect is body-building, disappear pain, heart tonifying, dissipating bind, detumescence, relaxing tendons and activating collaterals；Olibanum myrrh is made
With for blood-activating and qi-promoting analgesic, detumescence and promoting granulation, dissipate blood and dissolving stasis.The effect of monkshood radix aconiti agrestis is dispelling wind and eliminating dampness, Wen Jing, eliminating cold to stop pain.The bletilla striata
Effect is astringing to arrest bleeding, detumescence and promoting granulation.
Patient 1, female, and 55 years old, the XiaoShan, HangZhou City, Zhejiang Province area town Ning Wei people from the village Meng Er, accidentally foot fracture of carpal bone, three
Hospital all suggests that she performs an operation, she fears just to be fixed with gypsum, goes film making not grow after one month, hospital still suggests that she does hand
Art, she still fears to perform an operation, using relieving pain, fracture healing after plaster of the invention.
Patient 2, female, and 82 years old, Xianyang, Shanxi province city Sanyuan County Xiqin people from village of the township Gao Qu accidentally fell down before 10 years, formed
Bifid sacrum, used many methods are not all imitated, and recovery from illness after the patch of plaster 20 provided by the invention has been used.
Patient 3, female, and 26 years old, Nanyang City, Henan Province Tanghe County Datang people from center cell brought to a halt on bus and cause female
Child's cervical spine injury, in hospital three months more live it is more serious, in hospital during traction therapeutic, effect are bad everyday.By using the present invention
After plaster 20 days of offer, feeling of pain disappears, and disease is cured.
Patient 4, female, and 52 years old, Xinjiang Urumqi city Tianshan District Citroen zx street 839 people.It suffered from breast cancer and receives and distributes before 8 years
Art.It paints arthrosynovitis more than ten years, used a lot of method treatments are not all cured, and sodium hyaluronate was beaten.It is provided using the present invention
Externally applied ointment treat two months after, paint arthritis pain disappears, and walking is normal.
Patient 5, female, and 83 years old, people from Handan City suffered from rheumatic arthritis more than 30 years, can not normal walking, mentioned using the present invention
After the externally applied ointment treatment two weeks of confession, feeling of pain disappears.
Patient 6, male, and 56 years old, Shijiazhuang City Zhao County North town people from the village Gou An.Patient obtained gonarthromeningitis before 4 years,
It is very painful, it can not go to work in the fields, squatting motion can not be carried out, leg can only be bent 160 degree or so, and film making checks double fracture
Hyperplasia seeks medical advice and medicine all do not feel any better everywhere, and after having used four externally applied ointments provided by the invention, heel and thigh are with energy
It is enough close to, is able to carry out squatting motion, feeling of pain disappears.
Patient 7, female, and 60 years old, people from Handan City suffered from talagia for many years, and many places treatment is not all felt any better, and used four present invention
After the externally applied ointment of offer, feeling of pain disappears, even if will not still feel pain when stamping one's foot.
Patient 8, female, and 48 years old, the great landscape cell people in the area Gao Kai of Handan City ten thousand.Suffer from prolapse of lumbar intervertebral disc sciatic nerve crush, aches
Pain unbearably, cannot sit highly difficult on foot sometimes, cannot hurry up, use externally applied ointment provided by the invention after one month, pain
Sense disappears, and walking is normal.
Patient 9, and male, Shandong people from Zhou Cheng suffers from cervical vertebra and involve half of the first decade, during which repeatedly massage, have no and be clearly better, and use
After one month, feeling of pain disappears externally applied ointment provided by the invention.
Patient 10, female, and 60 years old, Shandong people from Zhou Cheng, hospital's film making checked that osteoproliferation is walked unusual pain, and the present invention has been used
After externally applied ointment one month of offer, feeling of pain disappears, on foot easily.
Second embodiment：
The externally applied ointment for being used to treat fracture acute and chronic bruise and rheumatism bone disease of the present embodiment, the composition component of plaster are pressed
Weight proportion is:It is 28 parts of lopseed, 17 parts of Big White Flower snake, 7 parts of gecko, 24 parts of Eupolyphoge sinensis, 30 parts of Resina Draconis, 34 parts of the rhizome of davallia, red
It spends 39 parts, 17 parts of Rhizoma Gastrodiae, 17 parts of Cortex Eucommiae, 35 parts of Caulis Spatholobi, 60 parts of pangolin, 28 parts of leech, 17 parts of hippocampus, 34 parts of olibanum, have
34 parts of medicine, 13 parts of Rhizoma Arisaematis (processed), 24 parts of native copper, 29 parts of corydalis tuber, 9 parts of the bletilla striata, 14 parts of aconiti preparata,radix, 14 parts of wild aconite root, 29 parts of Radix Angelicae Sinensis,
28 parts of Radix Astragali, 28 parts of radix dipsaci, 550 parts of yellow lead.
Obviously, described embodiment is only a part of the embodiments of the present invention, instead of all the embodiments.It is based on
Embodiment in the present invention, it is obtained by those of ordinary skill in the art without making creative efforts every other
Embodiment shall fall within the protection scope of the present invention.
Claims (3)
1. a kind of for treating the externally applied ointment of fracture acute and chronic bruise and rheumatism bone disease, which is characterized in that the plaster
Composition component be by weight ratio:20 ~ 30 parts of lopseed, 15 ~ 20 parts of Big White Flower snake, 5 ~ 10 parts of gecko, 20 ~ 30 parts of Eupolyphoge sinensis,
25 ~ 35 parts of Resina Draconis, 20 ~ 25 parts of the rhizome of davallia, 35 ~ 40 parts of safflower, 15 ~ 20 parts of Rhizoma Gastrodiae, 15 ~ 20 parts of Cortex Eucommiae, Caulis Spatholobi 30 ~ 40
Part, 55 ~ 65 parts of pangolin, 20 ~ 30 parts of leech, 15 ~ 20 parts of hippocampus, 30 ~ 35 parts of olibanum, 30 ~ 35 parts of myrrh, Rhizoma Arisaematis (processed) 10 ~ 15
Part, 20 ~ 25 parts of native copper, 20 ~ 30 parts of corydalis tuber, 5 ~ 10 parts of the bletilla striata, 10 ~ 15 parts of aconiti preparata,radix, 10 ~ 15 parts of wild aconite root, Radix Angelicae Sinensis 20 ~ 30
Part, 20 ~ 30 parts of Radix Astragali, 20 ~ 30 parts of radix dipsaci, 550 parts of yellow lead.
2. a kind of for treating the manufacturing method of the externally applied ointment of fracture acute and chronic bruise and rheumatism bone disease, feature exists
In including the steps that following：
S1：Obtain following material：20 ~ 30 parts of lopseed, 15 ~ 20 parts of Big White Flower snake, 5 ~ 10 parts of gecko, 20 ~ 30 parts of Eupolyphoge sinensis, dragon's blood
Exhaust 25 ~ 35 parts, 20 ~ 25 parts of the rhizome of davallia, 35 ~ 40 parts of safflower, 15 ~ 20 parts of Rhizoma Gastrodiae, 15 ~ 20 parts of Cortex Eucommiae, 30 ~ 40 parts of Caulis Spatholobi, water
20 ~ 30 parts of leech, 30 ~ 35 parts of olibanum, 30 ~ 35 parts of myrrh, 10 ~ 15 parts of Rhizoma Arisaematis (processed), 20 ~ 30 parts of corydalis tuber, 10 ~ 15 parts of aconiti preparata,radix, system
These medicinal materials, are broken into powder by 10 ~ 15 parts of radix aconiti agrestis, 20 ~ 30 parts of Radix Angelicae Sinensis, 20 ~ 30 parts of Radix Astragali, 20 ~ 30 parts of radix dipsaci；
S2：Material after S1 is smashed is impregnated 10 days to 20 days with 1.2 kilograms of sesame oil；
S3：The dregs of a decoction, which are filtered out, with 120 mesh sieve after tanning is further continued for oil of decocting medicinal herbs；
S4：Tanning medicine oil lower 550 parts of yellow lead after dropping into a bead, is persistently stirred, the process of lower yellow lead continues 5 during lower yellow lead
To 10 minutes；
S5：It is poured slowly into cold water, impregnates 7 to 15 days after cooling, and water of replacement daily, obtain lotion；
S6:20 ~ 25 parts of native copper, 55 ~ 65 parts of pangolin, 15 ~ 20 parts of hippocampus, 5 ~ 10 parts of the bletilla striata are beaten into powder and cross the addition of 120 meshes
It into lotion, is spread out on pure cotton cloth, freezing obtained finished product externally applied ointment after 48 hours.
3. externally applied ointment according to claim 1 as treatment fracture, osteoproliferation, acute and chronic bruise, lumbar muscle strain,
Prolapse of lumbar intervertebral disc, paint arthrosynovitis, facial paralysis, cervical spondylosis, scapulohumeral periarthritis, tennis elbow, talagia, rheumatoid arthritis, femur
The purposes of downright bad, ankylosing spondylitis the drug of head.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810722467.5A CN108904710A (en) | 2018-07-04 | 2018-07-04 | It is a kind of for treating the externally applied ointment and manufacturing method of bruise and rheumatism bone disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810722467.5A CN108904710A (en) | 2018-07-04 | 2018-07-04 | It is a kind of for treating the externally applied ointment and manufacturing method of bruise and rheumatism bone disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108904710A true CN108904710A (en) | 2018-11-30 |
Family
ID=64425441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810722467.5A Pending CN108904710A (en) | 2018-07-04 | 2018-07-04 | It is a kind of for treating the externally applied ointment and manufacturing method of bruise and rheumatism bone disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108904710A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1288736A (en) * | 2000-09-22 | 2001-03-28 | 李俊彪 | Medicine for protrusion of lumber vertebral disc and its preparation |
| CN101612279A (en) * | 2009-07-31 | 2009-12-30 | 徐先启 | A kind of Chinese medicine preparation that promotes union of fracture |
| CN104096087A (en) * | 2014-07-22 | 2014-10-15 | 刘其星 | Externally applied plaster for treating lumbar disc herniation |
| CN105998721A (en) * | 2016-05-09 | 2016-10-12 | 刘长水 | Bone-setting drug remarkable in treating effect and preparation method thereof |
-
2018
- 2018-07-04 CN CN201810722467.5A patent/CN108904710A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1288736A (en) * | 2000-09-22 | 2001-03-28 | 李俊彪 | Medicine for protrusion of lumber vertebral disc and its preparation |
| CN101612279A (en) * | 2009-07-31 | 2009-12-30 | 徐先启 | A kind of Chinese medicine preparation that promotes union of fracture |
| CN104096087A (en) * | 2014-07-22 | 2014-10-15 | 刘其星 | Externally applied plaster for treating lumbar disc herniation |
| CN105998721A (en) * | 2016-05-09 | 2016-10-12 | 刘长水 | Bone-setting drug remarkable in treating effect and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 吴富林: "《针刀医学临床实践》", 31 January 2008, 天津科学技术出版社 * |
| 孙树椿 主编: "《中医骨伤学 高级教程》", 31 March 2018, 中华医学电子音像出版社 * |
| 林乾良: "《简易效方》", 31 January 2012, 中国中医药出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101297946B (en) | Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof | |
| CN102552613B (en) | Externally applied Chinese medicinal paste for treating lumbar disc diseases | |
| CN1742994A (en) | Chinese foot-soaking powder | |
| CN104288538A (en) | Plaster for treating neck, shoulder, waist and leg diseases and preparation method of plaster | |
| CN103110863A (en) | Collateral-activating blood stasis-dispersing capsules | |
| CN101450197B (en) | Traditional Chinese medicine for treating rheumatism, rheumatoid disease | |
| CN1362202A (en) | Spur and rheumatism treating plaster | |
| CN100345573C (en) | Medicine for treating traumatic injury | |
| CN102861196B (en) | Traditional Chinese medicine for setting bones | |
| CN102755622B (en) | Medicine for treating rheumatoid arthritis | |
| CN101474396B (en) | Pharmaceutical composition for treating rheumatism and atrophic arthritis | |
| CN103599233B (en) | Bone hyperplasia rehabilitation medicinal liquor | |
| CN108904710A (en) | It is a kind of for treating the externally applied ointment and manufacturing method of bruise and rheumatism bone disease | |
| CN103386064A (en) | Traditional Chinese medicine patch | |
| CN103463348B (en) | A kind of orthopaedics balm | |
| CN112870283A (en) | A Chinese medicinal patch and its preparation method | |
| CN101708324B (en) | Plaster used for treating femoral head necrosis and preparation method thereof | |
| CN101194985B (en) | Orally taken Chinese medicine composition for treating articulatio genus hyperosteogeny | |
| CN104644928A (en) | Medicine for treating cervical and lumbar disc herniations | |
| CN109985210A (en) | A kind of Chinese medicine composition and preparation method thereof for treating treating rheumatic ostealgia | |
| CN109172786A (en) | A kind of draft energy mud formula of clearing damp dispelling cold and preparation method thereof | |
| CN108186983A (en) | It is a kind of to be used to treat plaster of rheumatism bone disease and preparation method thereof | |
| CN103083489B (en) | Traditional Chinese medicine wine for treating lumbar spondylosis, cervical spondylosis, early osteoproliferation and old wounds | |
| CN107753896A (en) | A kind of saussurea involucrata Wind-dispelling ointment and preparation method thereof | |
| CN106266153A (en) | A kind of for Chinese medicine composition dredging collaterals of human and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181130 |